These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27313229)

  • 1. Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 season.
    Li X; Deem MW
    Protein Eng Des Sel; 2016 Aug; 29(8):309-15. PubMed ID: 27313229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons.
    Monamele GC; Vernet MA; Njankouo MR; Victoir K; Akoachere JF; Anong D; Njouom R
    PLoS One; 2017; 12(9):e0184411. PubMed ID: 28877235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains.
    Galli C; Orsi A; Pariani E; Lai PL; Guarona G; Pellegrinelli L; Ebranati E; Icardi G; Panatto D
    Expert Rev Vaccines; 2020 Jan; 19(1):115-122. PubMed ID: 31875483
    [No Abstract]   [Full Text] [Related]  

  • 4. Interim estimates of divergence date and vaccine strain match of human influenza A(H3N2) virus from systematic influenza surveillance (2010-2015) in Hangzhou, southeast of China.
    Li J; Zhou YY; Kou Y; Yu XF; Zheng ZB; Yang XH; Wang HQ
    Int J Infect Dis; 2015 Nov; 40():17-24. PubMed ID: 26417878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct molecular evolution of influenza H3N2 strains in the 2016/17 season and its implications for vaccine effectiveness.
    Kim JI; Park S; Chu H; Lee I; Bae JY; Yoo K; Kim J; Lee JY; Lee N; Kim M; Kim JS; Hong KW; Jun KR; Lee JN; Kim K; Park MS
    Mol Phylogenet Evol; 2019 Feb; 131():29-34. PubMed ID: 30399431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Zost SJ; Parkhouse K; Gumina ME; Kim K; Diaz Perez S; Wilson PC; Treanor JJ; Sant AJ; Cobey S; Hensley SE
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12578-12583. PubMed ID: 29109276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the lookout for influenza viruses in Italy during the 2021-2022 season: Along came A(H3N2) viruses with a new phylogenetic makeup of their hemagglutinin.
    Galli C; Pellegrinelli L; Giardina F; Ferrari G; Uceda Renteria SC; Novazzi F; Masi E; Pagani E; Piccirilli G; Mauro MV; Binda S; Corvaro B; Tiberio C; Lalle E; Maggi F; Russo C; Ranno S; Vian E; Pariani E; Baldanti F; Piralla A;
    Virus Res; 2023 Jan; 324():199033. PubMed ID: 36581046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and antigenic characterization of hemagglutinin of influenza A/H3N2 virus from the 2015 season in Thailand.
    Tewawong N; Suntronwong N; Vichiwattana P; Vongpunsawad S; Theamboonlers A; Poovorawan Y
    Virus Genes; 2016 Oct; 52(5):711-5. PubMed ID: 27146171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of HA1 domain of influenza A/H3N2 viruses isolated in Kenya during the 2007-2013 seasons reveal significant divergence from WHO-recommended vaccine strains.
    Nyang'au EM; Bulimo WD; Mobegi V; Opanda S; Magiri E
    Int J Infect Dis; 2020 Jun; 95():413-420. PubMed ID: 32276045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
    Skowronski DM; Sabaiduc S; Leir S; Rose C; Zou M; Murti M; Dickinson JA; Olsha R; Gubbay JB; Croxen MA; Charest H; Bastien N; Li Y; Jassem A; Krajden M; De Serres G
    Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Antibody Recognition of H3N2 Vaccine and Seasonal Influenza Virus Strains Based on Age, Vaccine Status, and Sex in the 2017-2018 Season.
    Ursin RL; Liu H; Powell HR; Westerbeck JW; Shaw-Saliba K; Sylvia KE; Fenstermacher KJ; Mehoke T; Thielen P; Rothman RE; Pekosz A; Klein SL
    J Infect Dis; 2020 Sep; 222(8):1371-1382. PubMed ID: 32496543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in Denmark.
    Trebbien R; Fischer TK; Krause TG; Nielsen L; Nielsen XC; Weinreich LS; Lis-Tønder J; Skov MN; Christiansen CB; Emborg HD
    J Clin Virol; 2017 Sep; 94():1-7. PubMed ID: 28697450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season.
    López-Labrador FX; Natividad-Sancho A; Pisareva M; Komissarov A; Salvatierra K; Fadeev A; Moya A; Grudinin M; Díez-Domingo J; Afanasieva O; Konovalova N; Sominina A; Puig-Barberà J
    J Clin Virol; 2016 Nov; 84():32-38. PubMed ID: 27690141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort.
    Kissling E; Pozo F; Buda S; Vilcu AM; Gherasim A; Brytting M; Domegan L; Gómez V; Meijer A; Lazar M; Vučina VV; Dürrwald R; van der Werf S; Larrauri A; Enkirch T; O'Donnell J; Guiomar R; Hooiveld M; Petrović G; Stoian E; Penttinen P; Valenciano M;
    Euro Surveill; 2019 Nov; 24(48):. PubMed ID: 31796152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand.
    Suntronwong N; Klinfueng S; Vichiwattana P; Korkong S; Thongmee T; Vongpunsawad S; Poovorawan Y
    PLoS One; 2017; 12(12):e0189511. PubMed ID: 29252990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modular epitope binding predicts influenza quasispecies dominance and vaccine effectiveness: Application to 2018/19 season.
    Bonomo ME; Kim RY; Deem MW
    Vaccine; 2019 May; 37(24):3154-3158. PubMed ID: 31060950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic characterization of influenza A virus and assessment of vaccine efficacy in Yantai from 2014 to 2017].
    Liu J; Xu YC; Sun ZL; Gao Q; Dong ZJ; Xu XW; Gong LF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Aug; 53(8):840-842. PubMed ID: 31378046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced cross-protection against influenza A(H3N2) subgroup 3C.2a and 3C.3a viruses among Finnish healthcare workers vaccinated with 2013/14 seasonal influenza vaccine.
    Haveri A; Ikonen N; Julkunen I; Kantele A; Anttila V; Ruotsalainen E; Nohynek H; Lyytikainen O; Savolainen-Kopra C
    Euro Surveill; 2015 Feb; 20(5):21028. PubMed ID: 25677051
    [No Abstract]   [Full Text] [Related]  

  • 20. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
    Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.